Rifaximin dose‐finding study for the treatment of small intestinal bacterial overgrowth

Abstract

Higher doses of rifaximin lead to a significant gain in terms of therapeutic efficacy in small intestinal bacterial overgrowth eradication without increasing the incidence of side-effects.